Nordic AD Symposium

Nordic Alzheimer's Disease Symposium

5th – 6th September 2025
• Stockholm / Arlanda

The objective for the Nordic Alzheimer’s Disease symposium is to establish an annual Nordic scientific meeting place, gathering specialist healthcare professionals within the therapeutic area of Alzheimer’s disease (AD).

The symposium aims to cover scientific and clinical relevant aspects of AD, and this year the focus will be on the evolving treatment landscape, including new disease modifying treatments (DMTs) and diagnostic tools – a new chapter in Alzheimer’s disease.

The meeting is initiated, organised and funded by BioArctic and Eisai. Venue, speaker fees and food are financed by the companies.

The meeting is intended for specialist healthcare professionals within the therapeutic area of Alzheimer’s disease (AD).

Contact and Questions

If you have any questions, feel free to reach out

Questions regarding the programme:

Therese Feinberg
Nordic Brand Manager, BioArctic
therese.feinberg@bioarctic.com

Nils Gamlem
Medical Advisor, BioArctic
nils.gamlem@bioarctic.com

Phone +46 8 695 69 30

Questions regarding registration and logistics

Linda Flinthammar
linda.flinthammar@evolvemeetings.se

We look forward to your participation!

Eisai AB

Phone: +46 (0) 8 501 016 00
Email: nordic_medinfo@eisai.net

BioArctic AB

Phone: +46 (8) 695 6930
Email: nordics@bioarctic.com

Adverse events, quality complaints and medical information enquiries

If you wish to report an adverse event, quality complaint or have a medical enquiry concerning a product marketed by BioArctic and Eisai, please use the details below:

BioArctic AB
Phone: +46 (8) 695 6930
Email: medinfo@bioarctic.com

Eisai AB
Phone: +46 (0) 8 501 016 00
Email: nordic_medinfo@eisai.net

Purpose of the nordicadsymposium.com website

An Information hub for Nordic healthcare professionals in the therapeutic area of Alzheimer’s Disease

Welcome to Campus Alzheimer® – a digital platform designed specifically for healthcare professionals in the Nordic region, focusing on the early diagnosis and treatment of Alzheimer’s disease.

Campus Alzheimer is a collaborative initiative by BioArctic AB and Eisai AB, aimed at providing valuable insights and knowledge about the early diagnosis and treatment of Alzheimer’s disease. Our goal is to establish a resource where healthcare professionals can access relevant and up-to-date information on Alzheimer’s disease diagnosis and treatment, discover new research findings, explore training opportunities, learn about upcoming events, and find other useful information related to treatment in this field.

By consolidating knowledge, clinical experience, and educational resources in one place, we aspire to contribute to a new chapter in the management of Alzheimer’s disease.

Du är på väg att lämna nordicadsymposium.com. Vi rekommenderar att du noggrant läser den nya webbplatsens juridiska information och integritetspolicy för att säkerställa att innehållet är relevant för dig. Klicka på OK för att fortsätta eller Avbryt om du vill stanna kvar.